News
MS and (non-COVID) vaccinations: consensus recommendations
The document proposes a global vaccination strategy for the general MS patient population and selected subpopulations.
News
ECTRIMS/EAN statement on COVID-19 vaccination in patients with MS
The statement concludes that the COVID-19 vaccines that are currently available are safe for patients with MS.
News
Ublituximab improves functional MS score: New ULTIMATE analysis
Trial data are being used to support a recent approval application to the FDA for ublituximab to treat patients with relapsing remitting MS.
News
COVID-19 vaccination in MS: Lower response on certain medications
Currently approved COVID-19 vaccines appear safe in patients with MS and are effective in most patients.
News
USPSTF rules out aspirin for over 60s in primary CVD prevention
New draft recommendations from the U.S. Preventive Services Task Force (USPSTF) on the use of aspirin for the primary prevention of cardiovascular...
News
CVST after COVID-19 vaccine: New data confirm high mortality rate
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”
News
SSaSS: Salt substitute shows clear reduction in stroke, CV events, death
Switching from regular salt to a low-sodium salt substitute showed a reduction in stroke, cardiovascular events, and death, the new landmark SSaSS...
News
MASTER DAPT: 1 month DAPT enough after high-bleeding-risk PCI
The study gives the first prospective randomized evidence for abbreviated dual antiplatelet therapy in this group of patients with high risk for...
News
Statins again linked to lower COVID-19 mortality
Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t...
News
Meta-analysis supports cardiovascular benefits of EPA
Omega-3 fatty acids improved cardiovascular outcomes, with a greater risk reduction in studies of eicosapentaenoic acid alone rather than combined...
News
Large vessel stroke linked to AstraZeneca COVID vaccine
Three cases occurred in two women and one man in their 30s or 40s and involved blockages of the carotid and middle cerebral artery.
News
New STRENGTH analysis reignites debate on omega-3 CV benefits
The new analysis showing no benefits linked to higher achieved levels of EPA casts doubt over the use of high-dose omega-3 fatty acid products for...
News
ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found...